Q4074 HCPCS Level II code: Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
Q4074 is the HCPCS code for “Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q4074Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
Short description: Iloprost non-comp unit dose
HCPCS · United States
Medicare details
The indicators CMS publishes with Q4074 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Drugs Administered through DME
- Added
- Jan 1, 2010
Where Q4074 sits
- 1Q codesTemporary codes
- 2Active code Q4074Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q4074 mean?
Q4074 is the HCPCS code for “Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q4074?
CMS lists Q4074’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q4074
All Q codesQ4046Cast supplies, short leg splint, adult (11 years +), fiberglassQ4047Cast supplies, short leg splint, pediatric (0-10 years), plasterQ4048Cast supplies, short leg splint, pediatric (0-10 years), fiberglassQ4049Finger splint, staticQ4050Cast supplies, for unlisted types and materials of castsQ4051Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)Q4081Injection, epoetin alfa, 100 units (for esrd on dialysis)Q4082Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)Q4100Skin substitute, not otherwise specifiedQ4101Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)Q4102Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)Q4103Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)